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Placebo responses contribute substantially to the effect and clinical outcome of
medical treatments. Patients’ expectations have been identified as one of the major
mechanisms contributing to placebo effects. However, to date a general theoretical
framework to better understand how patient expectations interact with features of
medical treatment has not been developed. In this paper we outline an expectation
model that can be used as framework for experimental studies on both placebo and
nocebo mechanisms. This model is based on psychological concepts of expectation
development, expectation maintenance, and expectation change within the typical
paradigms used in placebo research. This theoretical framework reflects the dynamic
aspects of the interaction between expectations and medical treatment, and offers a
platform to combine psychological and neurophysiological research activities. Moreover,
this model can be used to identify important future research questions. For example, we
argue that the dynamic processes of expectation maintenance vs. expectation changes
are not sufficiently addressed in current research on placebo mechanisms. Therefore,
the question about how to change and optimize patients’ expectations prior to treatment
should be a special focus of future clinical research.
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INTRODUCTION
Placebo mechanisms contribute substantially to clinical outcome in many fields of medicine
(Schedlowski et al., 2015). In randomized clinical trials, patients receiving placebo treatment
typically achieve results that are almost equivalent to the response of the active intervention group.
This has been shown not only for patient reported outcomes, such as pain and depression, but
also for objectively assessed biological parameters such as immune reactions (Schedlowski et al.,
2015), cardiovascular reactions (Meissner, 2008), or polysomnographic assessments of pain and
sleep variables (Winkler and Rief, 2015).
Expectations have been identified as one of the major components contributing to placebo
reactions (Schwarz et al., 2016). If patients have a need for medical interventions, they are exposed
to stimuli in the clinical setting that trigger specific treatment- and outcome expectations. These
stimuli include the nature of the treatment itself—such as surgery, medicines, or injections. They
also include the characteristics of the clinician and the relationship formed with the patient
as well as the doctor’s confidence in the therapy and explanation of the treatment. The wider
treatment context such as the reputation of the facility and status of the clinic may also impact
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on treatment outcome expectations. As these are all factors
that operate psychologically to enhance or decrease the placebo
response, expectation theories can contribute to a better
understanding of placebo effects. In this paper, we will use
the terms expectation and expectancy interchangeable, although
expectancy is more frequently used when also including implicit
expectations and implicit expectation effects.
Atkinson’s expectancy-value theory outlines that behavior in
challenging situations is predicted by the interaction of prior
expectations to be able to manage such a challenge successfully
and the subjective value of the specific task (Atkinson and
Reitman, 1956). In the health setting, the value of the challenge
is typically associated with the hope to survive the illness and to
reduce the burden caused by its pain and symptoms. According
to the theory, a better clinical outcome is predicted if the expected
improvements caused by a treatment are of high personal value
and patients have a strong self-belief to be able to cope with the
situation (self-efficacy). Indeed, low expectations of specific self-
efficacy, and low expectations of therapy-driven improvements
result in low treatment adherence (Horne and Weinman, 2002).
A further relevant background theory is “prospect theory”
developed by Kahneman and Tversky (1979). This theory
emphasizes the subjectivity of the definition by which an outcome
can be considered as gains vs. losses. The authors highlight
the fact that potential losses are frequently more relevant for
behavioral decisions than expected gains. Applying this theory
to the clinical context, patients’ anxieties, and concerns about
treatment can be more relevant to predict their behavior than the
expected benefits of their treatment.
Expectations are frequently developed through a process
of associative learning. An important model predicting how
repeated trials of associative learning can lead to learned
reactions is Rescorla-Wagner’s model, which has been
principally developed to explain Pavlovian conditioning effects
(Rescorla, 1967). This model has also substantial relevance
for understanding the development and the consequences of
expectations. The power of an expectation corresponds in
part to the associative strength in the formula of this model.
Accordingly, the strength of expectation is dependent on the
number of trials confirming these associations and/or the
learning rate. Additionally, the model also postulates that
expectations can eventually achieve a maximum level that limits
further increases in association. Learning is reconceptualized as
a change of expectations. Therefore, the discrepancy between
expected outcome and experienced outcome is a major
precondition to initiate learning processes. The important
contribution of this model is for the understanding how
expectations are modified. The Rescorla-Wagner Model became
one of the basic concepts that stimulated the development of
paradigms investigating prediction and prediction error effects
in neuroscience (Schwarz et al., 2016).
While this selective collection of psychological theories
on expectation is not comprehensive, it illustrates that
these psychological theories have been developed with a
strong non-clinical focus. Therefore, we want to develop
a theoretical framework for expectation effects in the
clinical context, that offers a platform to integrate these
psychological theories with empirical approaches that will help
explain placebo and nocebo effects in the context of medical
treatments.
ADAPTING THE VIOLEX-MODEL
Recently, we developed a general model that conceptualizes how
expectations influence various outcomes in clinical psychology,
and when expectation violations lead to a change vs. a persistence
of expectations (“the ViolEx-model;” Rief et al., 2015). The
original model was developed as a broad theoretical framework to
better understand the dynamic interactions between expectation
effects, expectation violations, and their feedback loops to modify
expectations in general. Here, we adapt this model to placebo and
nocebo research and clinical encounters.
The core of the model in Figure 1 is the interaction of
expectations and clinical situations, such as visiting a doctor for
the treatment of bothersome symptoms. This interaction results
in predictions, outcome, and outcome evaluations that either
confirm or disconfirm pre-existing expectations. The model is
complemented by adding trait factors, past learning processes,
and state factors to better understand how expectations
developed. Different aspects of the model are covered below.
Placebo effects occur when a medical treatment and its
context trigger specific expectations about a positive therapeutic
outcome. Pre-existing optimistic expectations can amplify the
positive effects of treatments (placebo effects), but negative
expectations can also induce adverse treatment effects, such as
side effects or the absence of treatment-typical improvements
(nocebo effects).
The interaction of pre-existing generalized expectations and
medical setting variables leads to situations-specific predictions
that are associated with typical anticipatory reactions. When
a treatment outcome is perceived, an individual evaluates
whether it corresponds to the predicted outcome, or whether
the outcome is unpredicted, such as when side effects occur.
The more frequently expected positive outcomes occur then the
generalized expectations are more stable, although this learning
process is asymptomatic according to the Rescorla-Wagner-
Model (“confirmation,” see Figure 1). If the expected outcome
does not occur, or additional unexpected outcomes develop,
this will typically lead to a modification of expectations due to
expectation-violating experiences (“modification,” see Figure 1).
However, it would not be adaptive if individuals were to change
their expectations just because of one disconfirming event.
In reality, many people stick to their expectations despite
contradictory experiences (e.g., persistence of stereotypes about
population groups despite positive experiences with members
of them). In the clinical context, the change of expectations
is a crucial aspect, although this aspect has been poorly
investigated. Patients do not show up in clinical settings without
any treatment expectations, but these are not fully concordant
with what doctors would like them to expect about their
treatment. Therefore, it is quite typical that there is a conflict
between patients’ expectations (and fears) of a treatment vs.
doctors’ beliefs about the same therapy. Effects of self-generated
Frontiers in Psychology | www.frontiersin.org 2 November 2016 | Volume 7 | Article 1876
Rief and Petrie Expectation Models for Placebo
FIGURE 1 | Adaptation of the VIOL-EX model for placebo research.
expectations are usually stronger than expectations induced
from outside the individual (Acosta, 1982; Kemper et al., 2012;
Gaschler et al., 2014). The clinical task is thus not to establish
new expectations in “naïve” patients, but to change and optimize
pre-existing treatment expectations in patients.
Three factors contribute in particular to the development of
expectations (see Figure 1, yellow connections). These are prior
experience with the health care system (associative learning),
social influences about health issues that are established via
prior observations or learned indirectly from significant others
or through media sources such as the internet. The third
process that contributes is the individual personal construction
of assumptions as well as the direct instructions received from
others. As an example, observational learning is also of central
relevance in the clinical context. Patients often have contact or
observe other patients, be it in the waiting room of an outpatient
clinic, or in a typical inpatient setting. These other patients
can either praise or model the improvements from treatment,
discuss the skill of a particular doctor, or they can complain
about unwanted effects of interventions. The observation of such
behavior has been shown to influence the results of the observing
patient’s treatment (Colloca and Benedetti, 2009; Voegtle et al.,
2013; Faasse et al., 2015a).
Most of the associations indicated in Figure 1 are also
influenced by pre-existing trait factors (e.g., genetic factors,
personality factors), but also by state factors such as selective
attention or current options for memory retrieval. Expectancy
discrepant effects can lead to a “surprise-attention link” with
a shift of attention, which can facilitate or hinder learning
processes (Horstmann, 2015).
The “individual differences” mentioned on top of Figure 1
should be interpreted as a dimension influencing most other
processes on all levels of this model. The effect of expectations
can be also different depending whether they are self-
generated vs. cue-induced expectations (Gaschler et al., 2014),
with physician’s interventions representing more cue-induced
expectations. In part, this can help to explain why some
physician-induced expectations are less powerful than patient-
generated expectations.
EXAMPLES OF EMPIRICAL RESULTS TO
COMPONENTS OF THE EXPECTATION
MODEL
The most simple way to induce specific patients’ expectations
is by offering instructions about expected outcomes. In placebo
research, this is typically done by informing patients that a
placebo intervention is supposed to be a pain killer (Pollo
et al., 2001; Bingel et al., 2011). This effect can be further
amplified by inducing positive prior experiences with this specific
treatment. Manipulated feedback can also induce expectations
that (placebo) treatments can induce strong intervention
effects.
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Associative learning paradigms using Pavlovian conditioning
have been used to demonstrate influences on expectations, not
only in pain (Colloca and Benedetti, 2006), but also in various
other conditions. Using a similar design, we were able to show
that patients can “learn” to develop side effects if they received
several applications with the antidepressant amitriptyline, even if
eventually the drug is switched to a placebo pill (Rheker et al.,
2016). Further, many people have learned that effective drugs
are associated with some side effects that indicate the drug is
working or powerful. This led to work showing that so called
“active placebos” simulating drug-typical side effects inducemore
powerful placebo responses than “passive placebos” (Moncrieff
et al., 2004; Rief and Glombiewski, 2012; Benedetti et al., 2013).
Generalized expectations about medical treatments are not
only able to predict positive outcome, but also to predict the
development of side effects and other negative outcomes (Faasse
and Petrie, 2013). Promoting negative expectations can even
abolish the pain-relieving effects of powerful opioids, such as
remifentanil (Bingel et al., 2011). Negative beliefs about medicine
predict the development of more side effects (Nestoriuc et al.,
2010). This can take the form of a general belief that an individual
is highly sensitive to the effects of medication in general or
sensitive to specific type of medication (Horne et al., 2013;
Faasse et al., 2015b). For example, expectations about developing
medication side effects for endocrine therapy following breast
cancer predicts more problems after treatment onset (Nestoriuc
et al., 2016).
The context and environment that the medical treatment is
administered is of relevance, in particular, if it includes stimuli
that can activate expectations because of prior stimuli-associated
experiences. The treatment context can further amplify the effect
of positive expectations, e.g., if it is considered to be very
professional, friendly, and clean. Treatment-context conditions
are also able to influence the reactions to antidepressant drugs,
and can even trigger negative effects of antidepressants compared
to placebo (Rief et al., 2016). A special aspect of the treatment
context is the relationship between therapist and patient. While a
positive therapeutic relationship can predict successful treatment
outcome, a negative therapeutic relationships can also facilitate
the development of adverse treatment effects (Kaptchuk et al.,
2008; Koudriavtseva et al., 2012). Moreover, the quality of the
therapeutic relationship further predicts patients’ adherence, and
this association can also contribute to a positive outcome.
In experimental pain research, it has been shown that
situation-specific predictions of pain or pain relief activate brain
areas that facilitate the expected perceptions (Koyama et al.,
2005). When selecting actions (such as drug intake), the brain
pre-activates the representation of the predicted consequences
(Waszak et al., 2012).
Further biological and psychological pathways of action
of specific intervention predictions have been described
(Schedlowski et al., 2015). Of particular relevance is also the
role of selective attention. If patients expect adverse experiences,
they also focus their attention to the specific side effect expected,
which increases the perception intensity and facilitates the
reporting of adverse outcomes in general (Barsky et al., 2002)
or specific to the type of expectations generated (Crichton et al.,
2014). Attentional processes themselves can be the result of
learning (Mackintosh, 1975; Kruschke, 2003).
If the outcome is as positive as expected, this leads to a
confirmation of expectations consistent with the Rescorla-
Wagner Model; there is no change in association strength,
hence no learning. However, if expectations are not confirmed,
it remains unclear how the person will deal with that fact.
Several treatment approaches actually set out to induce
expectation violations (e.g., exposure therapy in anxiety
disorders; Craske et al., 2014; Craske, 2015). However, not
every expectation violation subsequently leads to expectation
changes. Frequently, patients activate cognitive-attributional
assimilation or immunization strategies to weaken or eliminate
the expectation violation. The result of successful exposure
sessions and other intended expectation violations can be
devaluated with cognitions such as: “this was the exception
to the rule;” “this only works if a therapist is close to me.” A
side-effect free day can still confirm side effect expectations
via attributions like: “if I didn’t get side effects today, I will
probably get them tomorrow.” While these assimilation and
immunization processes have been extensively studied in social
psychology, an examination of their role in clinical research is
still in a very early stage.
The dynamic process of expectation development,
maintenance, and change in the clinical context is further
influenced by biological and psychological trait and state factors.
Genetic aspects can predict whether a person is prone to develop
side effects (Wendt et al., 2014), as well as whether a person is
prone to develop placebo responses (Hall et al., 2012). Anxiety
as a personality factor is able to predict the development of
somatic symptoms as a reaction to medical interventions, but
also has potential as a predictor of symptom development caused
by expected environmental influences (Petrie et al., 2005; Page
et al., 2006; Witthöft and Rubin, 2013; Crichton et al., 2014). The
current level of biological stress reactions can further influence
the interaction of the components of our model. These are just
a few examples that the model presented in Figure 1, although
already elaborated, is still an approximation, and simplification
of the various influences that determine the interaction between
expectations and treatment settings.
CONCLUSION
The effect of the interaction between patients’ expectations
and treatment context depends on past experiences, and
they are characterized by dynamic interactions that happen
during and after the treatment encounter. Most components
are also influenced by biological and psychological individual
differences such as genetic, personality, and state factors. In
total, this model offers a theoretical framework that helps
to communicate and connect the different approaches on
placebo and nocebo research, both on a more basic scientific
level and in terms of clinical applications. It also helps
to identify research areas needing more work. One of the
specific conclusions we want to draw is that more research is
needed how to modify pre-existing expectations in situations
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where patients’ pre-treatment expectations are non-adaptive.
Therefore, the focus of research has to move from mere
inductions of specific expectations to a better understanding of
processes of expectation persistence, expectation violation, and
expectation change.
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